EntoBio Overview

  • Founded
  • 2015
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

EntoBio General Information


Developer of synthesizes insect digestive enzymes designed to break down cell walls and treat difficult compounds naturally. The company synthesizes insect digestive enzymes are liquid termite which improves the efficiency, sustainability and cost of working with products from vegetable oil to wood pulp to biofuels, by forgoing the need for excessive energy and chemicals, enabling the producer to reduce both the operating and capital cost, decreased hazardous chemicals and decreased inhibitory byproducts.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Commercial Products
Other Industries
Other Forestry
Primary Office
  • 4230 Lander Road
  • Chagrin Falls, OH 44022
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EntoBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 18-Mar-2021 0000 Completed Out of Business
4. Grant 01-Jan-2018 00000 0000 Completed Startup
3. Accelerator/Incubator 0000 Completed Startup
2. Grant 28-Dec-2015 $225K $25K Completed Startup
1. Accelerator/Incubator 03-Sep-2015 $25K $25K Completed Startup
To view EntoBio’s complete valuation and funding history, request access »

EntoBio Patents

EntoBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160353747-A1 Compositions and methods for achieving a biological effect in target vegetation Abandoned 08-Jun-2015